-
Amgen Inc. (AMGN $373.36)
-
Gilead Sciences Inc. (GILD $155.27)
-
Intuitive Surgical Inc. (ISRG $493.35)
-
Regeneron Pharmaceuticals Inc. (REGN $793.53)
-
Eli Lilly and Company (LLY $1,036.05)
-
Merck & Company Inc. (MRK $121.57)
Q: I just sold a position in Regeneron, and I am looking to replace it with another name in the healthcare space. I already hold ISRG, but I am reticent to add to it while it seems to trade sideways. Lilly has performed well, but I am unsure if it is now fully valued.A recent interviewee on CNBC had mentioned Amgen and Gilead as names which could do well. Any suggestions for names to consider in the healthcare space? I’d be okay with both Canadian and US names. Thanks so much, and I look forward to your response.